Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19-2 | COVID19 (COVID19 (MODERNA BIVALENT)) | MODERNA | UNK | NA0587 | IM / LA |
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Body Aches Generalized-Medium, Systemic: TENDER, PROGESSIVE SWELLING, INFLAMMED/HOT AREA-Medium, Additional Details: DIAGNOSIS AFTER DOCTOR VISIT: CELLULITIS OF THE UPPER LEFT ARM , Other Vaccines: VaccineTypeBrand: HEPLISAV-B; Manufacturer: DYNAVAX; LotNumber: 946912; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 1; VaxDate: 10/03/2025, VaccineTypeBrand: SHINGRIX; Manufacturer: GSK; LotNumber: 5YNCA; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 1; VaxDate: 10/03/2025, VaccineTypeBrand: ABRYSVO; Manufacturer: PFIZER; LotNumber: MD0315; Route: INTRAMUSCULAR; BodySite: LEFT ARM; Dose: 1; VaxDate: 10/03/2025
NOT AWARE